You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-neonatal Fc receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Natural Killer T Cells ExpressingInvariant T Receptor :

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Physiopathology
  • Blood sample
  • Tours, France
    University Hospital
May 12, 2023

COVID-19 Trial in Petach Tikva (no intervantion)

Active, not recruiting
  • COVID-19
  • no intervantion
  • Petach Tikva, Israel
    Schneider Children's Medical Center
Sep 29, 2022

Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus

Completed
  • Lupus Erythematosus, Systemic
  • Blood samples
  • Tours, France
  • +1 more
Feb 23, 2021

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Breast Cancer Trial in Besançon (additional blood sample)

Completed
  • Breast Cancer
  • additional blood sample
  • Besançon, France
    Centre Hospitalier Régional Universitaire
Apr 15, 2021

Guillain-Barre Syndrome Trial (Efgartigimod Alfa-Fcab, Intravenous Immunoglobulin (IVIg))

Not yet recruiting
  • Guillain-Barre Syndrome
  • Efgartigimod Alfa-Fcab
  • Intravenous Immunoglobulin (IVIg)
  • (no location specified)
Jan 17, 2023

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women

Recruiting
  • Pregnancy Related
  • +5 more
    • Milano, Italy
      ASST Fatebenefratelli e Sacco
    Jul 13, 2023

    Warm Autoimmune Hemolytic Anemia Trial in Riverside (ALXN1830, Placebo)

    Withdrawn
    • Warm Autoimmune Hemolytic Anemia
    • Riverside, California
      Clinical Study Site
    Feb 2, 2022

    Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Adult T-Cell Leukemia (ATL)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 13, 2022

    Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

    Terminated
    Has Results
    • Graves' Ophthalmopathy (GO)
    • RVT-1401 (Administered via subcutaneous injection)
    • Placebo (Administered via subcutaneous injection)
    • Beverly Hills, California
    • +24 more
    Aug 26, 2022

    The Research Registry for Neonatal Lupus

    Recruiting
    • Neonatal Lupus
    • +3 more
    • No intervention; observational
    • New York, New York
      Jill P. Buyon, MD
    Sep 6, 2022

    Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non-hodgkin Lymphoma,B Cell
    • Autologous CD19-STAR-T cell
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2022

    Graves' Ophthalmopathy Trial in Canada (RVT-1401)

    Completed
    Has Results
    • Graves' Ophthalmopathy
    • Vancouver, British Columbia, Canada
    • +3 more
    Dec 24, 2021

    Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

    Not yet recruiting
    • Advanced Solid Tumor
    • Refractory Non-Hodgkin Lymphoma
    • (no location specified)
    May 28, 2023

    HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

    Completed
    • HIV Antibodies
    • VRC-HIVMAB091-00-AB
    • EDP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 8, 2022

    Acute Myeloid Leukemia Trial in Valencia (AFM28)

    Recruiting
    • Acute Myeloid Leukemia
    • Valencia, Spain
      Hospital Universitari i Politècnic La Fe
    Apr 5, 2023

    NMO Spectrum Disorder Trial in Guangzhou (HBM9161 Injection)

    Completed
    • NMO Spectrum Disorder
    • HBM9161 Injection
    • Guangzhou, Guangdong, China
      Nanfang Hospital
    Jan 9, 2022

    ITP Trial in Suzhou (autologous anti-BCMA chimeric antigen receptor T cells)

    Recruiting
    • ITP
    • autologous anti-BCMA chimeric antigen receptor T cells
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Mar 31, 2022

    Safety Issues Trial in Cali (Neonatal thymus transplantation)

    Recruiting
    • Safety Issues
    • Neonatal thymus transplantation
    • Cali, Valle Del Cauca, Colombia
      Fundación Valle Del Lili
    Dec 14, 2022

    Severe Hemophilia A Trial in China (FRSW117)

    Not yet recruiting
    • Severe Hemophilia A
    • Beijing, China
    • +27 more
    Nov 16, 2023

    Severe Hemophilia A Trial in China (ADVATE, FRSW117)

    Completed
    • Severe Hemophilia A
    • Guangzhou, Guangzhou, China
    • +3 more
    Jun 27, 2022

    Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

    Recruiting
    • Advanced Cancer
    • +7 more
    • Scottsdale, Arizona
    • +14 more
    Sep 15, 2022

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023